Purchase Order 75N95D25P00046
Award Date
4/29/25
Potential Completion Date
5/30/25
Potential Value
$23K
Federal Agency
National Institute on Aging
Awardee
Illumina, Inc.
Ultimate Awardee
Not listed
NAICS Category
334516 - Analytical Laboratory Instrument Manufacturing
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
San Diego, CA 92122, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed price delivery order contract awarded by the National Institute on Aging (NIA), which is part of the National Institutes of Health (NIH), a civilian agency. The contract was awarded to Illumina, Inc., a for-profit manufacturer of genetic sequencing instruments and related products, for $124,364.28. The contract is for "INFINIUM METHYLATION" services and does not have a set-aside designation. Illumina is the prime contractor and has not issued any identified...
This is a $103,520.31 firm fixed price delivery order awarded by the National Institute on Aging (NIA), a civilian agency, to Illumina, Inc., a for-profit manufacturer of sequencing and genomic analysis instruments and reagents. The award is for the provision of Illumina's Infinium Methylation Array, targeting 830,000 methylation sites, with a performance period ending on March 25, 2016. This contract has no set-aside designations. Illumina has previously received prime federal contracts and...
This federal contract award to Illumina, Inc., a leading manufacturer of genetic sequencing and genomic analysis technologies, was issued by the National Institute of Environmental Health Sciences (NIEHS), a civilian agency. The $20,198.50 firm fixed price purchase order does not have a set-aside designation. The contract is for the procurement of Illumina's advanced sequencing instruments, reagents, consumables, and bioinformatics software to support scientific research, healthcare, and...
This is a firm fixed price delivery order contract awarded by the National Institute on Aging (NIA), a civilian agency of the U.S. government, to Illumina, Inc., a manufacturer of genetic sequencing and analysis instruments and reagents. The contract has a ceiling value of $139,724.01 and was awarded on February 2, 2017, with a final completion date of March 4, 2017. The contract provides for the delivery of "INFINIUM METHYLATION SAMPLES" and does not have a set-aside designation....
This is a firm fixed price delivery order awarded by the National Institutes of Health (NIH) National Human Genome Research Institute to Illumina, Inc., a for-profit manufacturer of genomic sequencing and analysis products. The $147,003.32 award provides Illumina goods and services including sequencing systems, reagents, and related support for genomic research and diagnostics purposes. Illumina has a history of prime federal contract awards across agencies like NIH, CDC, USDA, and VA, supplying...
This is a firm fixed price delivery order awarded by the National Institute on Aging (NIA), a civilian agency within the National Institutes of Health (NIH), to Illumina, Inc. for $89,298.14. The award was made on September 6, 2017 and the ultimate completion date is September 2, 2020. Illumina is a manufacturer and provider of sequencing and array-based solutions for genetic and genomic analysis. This delivery order is likely part of a larger Indefinite Delivery Contract worth up to $3.3...
This is a firm fixed-price purchase order awarded by the National Human Genome Research Institute (NHGRI), a component of the National Institutes of Health (NIH), to Illumina, Inc., a manufacturer of sequencing and genomic analysis instruments and reagents. The $15,575 contract is for the delivery of Illumina's proprietary sequencing systems, reagents, and related products and services to support the Institute's genomic research and diagnostics activities. This award is not associated with any...
This is a firm fixed price delivery order contract awarded by the National Cancer Institute (part of the National Institutes of Health) to Illumina, Inc. The $24,163.80 contract is for the provision of various Illumina sequencing systems, reagents, and related services. Illumina is a manufacturer of genetic and genomic analysis instrumentation and solutions. The contract does not have a set-aside designation. Illumina has previously received other prime federal contracts and sub-awards from...
This is a firm fixed-price delivery order contract awarded by the National Human Genome Research Institute, part of the National Institutes of Health, to Illumina, Inc. The total ceiling value of the contract is $16,851.34 with a final completion date of September 1, 2025. Illumina, a for-profit manufacturer of genomic sequencing and analysis instruments and reagents, has been awarded this contract to provide a range of its NextSeq, NovaSeq, MiSeq, and iSeq sequencing systems, as well as...
This is a firm fixed-price delivery order awarded by the National Institute on Aging (NIA), a civilian agency, to Illumina, Inc., a manufacturer of sequencing and array-based solutions for genetic and genomic analysis. The contract is valued at $13,668.73 and does not have a set-aside designation. The award was made on July 26, 2018 with a period of performance through December 31, 2018. Illumina has previously received prime federal contract awards from agencies like the National Institutes...